Regarding matrix metalloproteinases, a recent study showed that inhibition of MMP-9 by a monoclonal antibody in an immuno-competent model of HER2-positive breast cancer increased tumor-suppressive T cell infiltration and CXCR3 chemokine expression. This evidence concerns the gene ERBB2 and breast cancer.